A Phase 1 Open Label Trial of Intravenous Administration of MVA-BN-Brachyury Vaccine in Patients With Advanced Cancer

NCT04134312 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Metastatic Tumor

Interventions

BIOLOGICAL: MVA-BN-Brachyury

Sponsor

Bavarian Nordic